As of November 1, 2023, patients should pay less at pharmacies for reimbursed drugs made in Poland or from Polish ingredients. Meanwhile, the health ministry has not published a list of drugs covered by the reduction, and it is not included in the draft announcement that will be in effect from January 1, 2024. The absence of this list means that public officials have failed to implement a mandatory provision of the law. It also exposes patients to financial damages amounting to at least several million zlotys per month.
The Health Ministry's actions are unlawful and violate existing regulations, three drug manufacturer organizations pointed out in their opinion to the Health Ministry's draft announcement on the list of reimbursed drugs, foodstuffs for special nutritional purposes and medical devices for January 1, 2024.
The Polish Association of Employers of the Pharmaceutical Industry - KRAJOWI PRODUCERS OF MEDICATIONS, the Economic Chamber FARMACJA POLSKA and the Polish Chamber of the Pharmaceutical Industry and Medical Devices POLFARMED have indicated that - contrary to...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
